Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Sep;68(17):2811-30.
doi: 10.1007/s00018-011-0677-7. Epub 2011 Apr 9.

The role of chemokines and their receptors in angiogenesis

Affiliations
Review

The role of chemokines and their receptors in angiogenesis

Friedemann Kiefer et al. Cell Mol Life Sci. 2011 Sep.

Abstract

Chemokines are a vertebrate-specific group of small molecules that regulate cell migration and behaviour in diverse contexts. So far, around 50 chemokines have been identified in humans, which bind to 18 different chemokine receptors. These are members of the seven-transmembrane receptor family. Initially, chemokines were identified as modulators of the immune response. Subsequently, they were also shown to regulate cell migration during embryonic development. Here, we discuss the influence of chemokines and their receptors on angiogenesis, or the formation of new blood vessels. We highlight recent advances in our understanding of how chemokine signalling might directly influence endothelial cell migration. We furthermore examine the contributions of chemokine signalling in immune cells during this process. Finally, we explore possible implications for disease settings, such as chronic inflammation and tumour progression.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Endothelial autonomous and non-autonomous roles of chemokines during angiogenesis. a Chemokines act directly on endothelial cells expressing chemokine receptors and thereby influence endothelial migration and angiogenesis. b Chemokines indirectly influence endothelial cell behaviours by attracting chemokine receptor-expressing leucocytes. These subsequently secrete proangiogenic factors, such as VEGF, that act on endothelial cells and initiate angiogenesis
Fig. 2
Fig. 2
The role of chemokine signalling during tumour formation. a Immune evasion. Chronic local inflammation caused by irritants or pathogens is accompanied by persistent leucocyte infiltration. Activated inflammatory macrophages secrete abundant growth factors and produce reactive oxygen and nitrogen species, which generate a mutagenic environment that ultimately initiates transforming events. b Angiogenesis. The forming hyperplastic tissue is a source of chemoattractants, including CCL2/MCP-1 and CSF-1, which recruit circulating monocytes. As these monocytes colonize the tumour, they are instructed by the tumour environment to differentiate into M2 type TAMs. Tumour cells may also express chemokine receptors and respond to autocrine and paracrine stimulation. c Tissue destruction/remodelling. Tumour growth is associated with accumulation of M2-type TAMs, which not only produce additional chemoattractants, but also actively suppress inflammatory and cytotoxic responses to the tumour. TAMs secrete proangiogenic factors that in addition to proangiogenic chemokines support tumour vascularization. TAMs also provide proteolytic activities that help the tumour to overcome constraining tissue borders and enhance metastasis. Throughout the entire development, new macrophages are recruited and subverted to serve the major objectives of the developing tumour. The major chemoattractant/growth factor producing cell types are highlighted on the right

Similar articles

Cited by

References

    1. Risau W. Mechanisms of angiogenesis. Nature. 1997;386(6626):671–674. - PubMed
    1. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling – in control of vascular function. Nat Rev Mol Cell Biol. 2006;7(5):359–371. - PubMed
    1. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996;380(6573):435–439. - PubMed
    1. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O’Shea KS, Powell-Braxton L, Hillan KJ, Moore MW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380(6573):439–442. - PubMed
    1. Nasevicius A, Larson J, Ekker SC. Distinct requirements for zebrafish angiogenesis revealed by a VEGF-A morphant. Yeast. 2000;17(4):294–301. - PMC - PubMed

Publication types

LinkOut - more resources